US 12042487
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
granted A61KA61K31/44A61K45/06
Quick answer
US patent 12042487 (Method for reducing side effects from administration of phosphodiesterase-4 inhibitors) held by ARCUTIS BIOTHERAPEUTICS, INC. expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCUTIS BIOTHERAPEUTICS, INC.
- Grant date
- Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/44, A61K45/06, A61K47/10, A61K47/24